Abemaciclib improved progression-free survival at 6 months in meningiomas with NF2 or CDK pathway alterations, achieving a 58 ...

Onvansertib in combination with both chemo/bev regimens was well-tolerated. There were no major or unexpected toxicities observed and no additive adverse events. Grade 3 or higher adverse events were ...

PFS-level studies are ongoing, with METS Engineering undertaking additional metallurgical test work to build on the high gold recoveries achieved at RPM to date (ASX Announcement: 5 August 2025), ...

Please provide your email address to receive an email when new articles are posted on . Women with advanced ovarian cancer derived significant quality-adjusted PFS benefit from niraparib compared with ...

BERLIN — Combining the off-the-shelf anticancer vaccine IO102-IO103 with pembrolizumab does not offer any progression-free survival (PFS) benefit in patients with untreated advanced melanoma vs ...

BERLIN — The investigational drug gedatolisib substantially extends progression-free survival (PFS) among patients with advanced hormone receptor (HR)-positive, HER2-negative breast cancer that has ...

Primerica's PFS Investments was hit with a securities class action on Oct. 10 in Texas Southern District Court. The lawsuit was brought by Peiffer Wolf Carr Kane Conway & Wise and Bixby Law on behalf ...

The movie theater at 1412 Chestnut St. has been closed for the past four months as crews gutted the lobby and upgraded the historic space, currently the home base of the Philadelphia Film Society. Now ...

Pirtobrutinib was associated with a statistically significant improvement in PFS compared with bendamustine plus rituximab therapy. Topline data were announced from a phase 3 trial evaluating ...

As federal regulators increasingly reward companies for self-reporting, self-regulation and cooperating with investigations, the case of a registered broker-dealer out of Georgia shows how early ...